Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Scientific Reports|May 5, 2022
Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19Cristina Cerrada-Romero, Judith Berastegui-Cabrera, Pedro Camacho-Martínez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2026
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Heloise Lucaccioni, Diogo Fp Marques, Freja Kirsebom, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 5, 2019
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohortEsther Kissling, Francisco Pozo, Silke Buda, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 4, 2024
Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24Gloria Pérez-Gimeno, Clara Mazagatos, Nicola Lorusso, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2025
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Mc Rose, Héloïse Lucaccioni, Kimberly Marsh, et al.
Frontiers in Public Health|May 28, 2024
The burden and treatment of non-communicable diseases among healthcare workers in sub-Saharan Africa: a multi-country cross-sectional studySophie Alice Müller, Kelly Elimian, Jean Florent Rafamatanantsoa, et al.
Journal of Clinical Microbiology|June 8, 2007
Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarrayPhenix-Lan Quan, Gustavo Palacios, Omar J Jabado, et al.
The Journal of Infectious Diseases|October 17, 2025
Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab AdministrationMaría Iglesias-Caballero, Vicente Mas, Albert Campoy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Pageof 21